home / stock / dphay / dphay news


DPHAY News and Press, Dechra Pharms Plc Adr From 05/23/22

Stock Information

Company Name: Dechra Pharms Plc Adr
Stock Symbol: DPHAY
Market: OTC
Website: dechra.com

Menu

DPHAY DPHAY Quote DPHAY Short DPHAY News DPHAY Articles DPHAY Message Board
Get DPHAY Alerts

News, Short Squeeze, Breakout and More Instantly...

DPHAY - Baron Growth Fund Q1 2022 Shareholder Letter

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Growth Fund (the "Fund") declined 13.33% (Institutional Shares) during the quarter ended March 31, 2022. We foc...

DPHAY - Baron Health Care Fund Q1 2022 Shareholder Letter

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2022, Baron Health Care Fund (the “Fund”) declined 9.93% (Institutional Shar...

DPHAY - Dechra Pharmaceuticals PLC GAAP EPS of $0.37, revenue of $332.4M

Dechra Pharmaceuticals PLC (OTC:DPHAY): 2H GAAP EPS of $0.37. Revenue of $332.4M (+10.9% Y/Y). For further details see: Dechra Pharmaceuticals PLC GAAP EPS of $0.37, revenue of $332.4M

DPHAY - Dechra Pharmaceuticals PLC (DPHAY) CEO Ian Page On Q2 2022 Results - Earnings Call Transcript

Dechra Pharmaceuticals PLC (DPHAY) Q2 2022 Earnings Conference Call February 21, 2022 4:00 AM ET Company Participants Ian Page - CEO Paul Sandland - CFO Conference Call Participants Max Herrmann - Stifel Anand Date - HSBC Mike Mitchell - Panmure Gordon Andrew Whitney - Investec Zoe Karamanoli...

DPHAY - Dechra Pharmaceuticals PLC 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Dechra Pharmaceuticals PLC in conjunction with their 2022 Q2 earnings call. For further details see: Dechra Pharmaceuticals PLC 2022 Q2 - Results - Earnings Call Presentation

DPHAY - Morrisons expected to enter FTSE 100 amid takeover bids

Morrisons (OTCPK:MRWSF +2.5%), the fourth largest UK supermarket chain, is poised to enter the FTSE 100 index. The company's shares surged 60% since June to a valuation of $9.6B after it received offers from private equity firms. Its inclusion in the index could be short given the bidders com...

DPHAY - Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually

The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets. Impressive margins and high growth is apparent across consumabl...

DPHAY - Harding Loevner Global Small Companies Equity Q1 2021 Letter

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...

DPHAY - Harding Loevner International Small Companies Equity Q1 2021 Letter

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. Performa...

DPHAY - Dechra: Hard To Justify The Valuation

U.K.-listed animal medicine maker Dechra ([[DPHAY]], [[DCHPF]]) published its annual report . The results were decent, but the strong share price run-up emphasises that the shares are not valued on fundamentals. I continue to think that the company is highly overvalued and is a definite sell....

Previous 10 Next 10